Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib after hepatic artery embolization for metastatic gastrointestinal neuroendocrine tumors
NCT00434109Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Nov 2006
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sunitinib in Neuroendocrine Neoplasm (NEN) and islet cell tumor, sponsored by Moffitt Cancer Center. Started Nov 2006; status: completed.
02
Drugs
sunitinib
03
Conditions
Neuroendocrine Neoplasm (NEN)islet cell tumor
Beyond the preview
Go deeper on NCT00434109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434109.